BSEInsider Trading / SAST3d ago · 17 Aug 2026, 02:25 pm

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Dhiren Chandulal Shah, Sunil Chinubhai Shah & PACs

Parmax Pharma Ltd · 540359

✦ AI SummaryPledge

Parmax Pharma Ltd has received a disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011, stating that Dhiren Chandulal Shah and Sunil Chinubhai Shah have acquired 11,52,450 equity shares of the company on August 13, 2026, pursuant to a Share Purchase Agreement dated June 08, 2026. This acquisition has increased their shareholding in the company to 58.01%.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern3/10
Regulatory Risk4/10
Balance Sheet Risk6/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Parmax Pharma Ltd - 540359 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Attachments (1)

📄

5333DD26_DC54_4E69_B3C3_EF70AD0C0C06_142500.pdf

pdf

Download →
View document text
SU IL CHI UBHAI SHAH Vidyabhavan, 22/39 New Jaganath Plot, Dr. Yagnik Road, Rajkot, Gujarat BSE Limited PhirozeJeejeebhoyTowers, Dalal Street, Mumbai-400001, Maharashtra TheCompanySecretary&ComplianceOfficer, ParmaxPharmaLtd. PlotNo.20,SurveyNo.52, Rajkot-GondalNationalHighwayNo.27, Hadamtala, Tal. Kotda Sangani,Rajkot-360311,India Gujarat Scrip ID: PARMAX | Scrip Code: 540359 Dear Sir/Madam, Sub: Disclosure under Regulation 29(2) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, asamended ("SEBI (SAST) Regulations") This is to inform you that, Dhiren Chandulal Shah (“Acquirer 1”) and Sunil Chinubhai Shah (“Acquirer 2”), Dhairya Dhiren Shah (“PAC 1”), Hiren Pravin Doshi (“PAC 2”), Sheetal Hiren Doshi (“PAC 3”), Nirmal Sunilbhai Shah (“PAC 4”), Vijaykumar Natvarlal Shiyani (“PAC 6”) and Kamlesh Natvarlal Shiyani (“PAC 7”), in terms of the SEBI (SAST) Regulations, have acquired 11,52,450 equity shares of face value of Rs. 10.00 each of Parmax Pharma Limited ("Target Company) on August 13, 2026 pursuant to the Share Purchase Agreement dated June 08, 2026. This disclosure is being submitted in compliance with Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. You are requested to kindly take the same on record and acknowledge receipt of this disclosure. Yourssiinncceerreellyy,, Name:SUNIL SHAH Acquirer 2 Place: Rajkot, Gujarat Date: August 14, 2026 SU IL CHI UBHAI SHAH Vidyabhavan, 22/39 New Jaganath Plot, Dr. Yagnik Road, Rajkot, Gujarat Format for disclosures under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 Parmax Pharma Limited Name of the Target Company (TC) Dhiren Chandulal Shah (“Acquirer 1”) and Name(s) of the acquirer and Persons Acting in Concert Sunil Chinubhai Shah (“Acquirer 2”) (PAC) with the acquirer Dhairya Dhiren Shah (“PAC 1”), Hiren Pravin Doshi (“PAC 2”), Sheetal Hiren Doshi (“PAC 3”), Nirmal Sunilbhai Shah (“PAC 4”), Rupa Sunil Shah (“PAC 5”), Vijaykumar Natvarlal Shiyani (“PAC 6”), Kamlesh Natvarlal Shiyani (“PAC 7”), Abhay Chinubhai Shah (“PAC 8”), Umang Alkesh Gosalia (“PAC 9”) and Meena Alkesh Gosalia (“PAC 10”) Whether the acquirer belongs to Promoter/Promoter group BSE Limited (“BSE”) Name(s) of the Stock Exchange(s) where the shares of TC Scrip Code: 540359 are Listed Number % w.r.t. total % w.r.t. total share / voting diluted Details of the acquisition / disposal as follows capital share/voting wherever capital of the TC applicable(*) (**) Before the acquisition under consideration, holding of : a) Shares carrying voting rights 10,17,714 27.20% 27.20% (Annexure A) b) Shares in the nature of encumbrance (pledge/ - - - lien/ non-disposal undertaking/ others) c) Voting rights (VR) otherwise than by shares - - - d) Warrants/convertible securities/any other - - - instrument that entitles the acquirer to receive shares carrying voting rights in the T C (specify holding in each category) e) Total (a+b+c+d) 10,17,714 27.20% 27.20% SU IL CHI UBHAI SHAH Vidyabhavan, 22/39 New Jaganath Plot, Dr. Yagnik Road, Rajkot, Gujarat Details of acquisition/sale a) Shares carrying voting rights acquired/sold 11,52,450 30.81% 30.81% (Annexure A) b) VRs acquired /sold otherwise than by shares - - - c) Warrants/convertible securities/any other - - - instrument that entitles the acquirer to receive shares carrying voting rights in the TC (specify holding in each category) acquired/sold d) Shares encumbered / invoked/released by the - - - acquirer e) Total (a+b+c+/-d) 11,52,450 30.81% 30.81% After the acquisition/sale, holding of: 21,70,164 58.01% 58.01% a) Shares carrying voting rights (Annexure A) b) Shares encumbered with the acquirer - - - c) VRs otherwise than by shares - - - d) Warrants/convertible securities/any other instrument that entitles the acquirer to receive - - - shares carrying voting rights in the TC (specify holding in each category) after acquisition e) Total (a+b+c+d) 21,70,164 58.01% 58.01% Mode of acquisition / sale (e.g. open market / off- Off market acquisition of equity shares pursuant to market / public issue / rights issue / preferential Share Purchase Agreement dated June 08, 2026 allotment / inter-se transfer etc). August 13, 2026 Date of acquisition / sale of shares / VR or date of receipt of intimation of allotment of shares, whichever is applicable !umber of Shares: 37,41,300 Equity share capital / total voting capital of the TC Amount (in ₹): 3,74,13,000 (Face Value of ₹ 10/- per before the said acquisition / sale equity share) !umber of Shares: 37,41,300 Equity share capital/ total voting capital of the TC Amount (in ₹): 3,74,13,000 (Face Value of ₹ 10/- after the said acquisition / sale per equity share) !umber of Shares: 37,41,300 Total diluted share/voting capital of the TC after Amount (in ₹): 3,74,13,000 (Face Value of ₹ 10/- per the said acquisition equity share) (*) Total share capital / voting capital to be taken as per the latest filing done by the company to the Stock SU IL CHI UBHAI SHAH Vidyabhavan, 22/39 New Jaganath Plot, Dr. Yagnik Road, Rajkot, Gujarat Exchange under Clause 35 of the listing Agreement. (**) Diluted share/voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities/warrants into equity shares of the TC. Signatureoftheacquirer/seller/AuthorisedSignatory !ame:SUNIL SHAH Acquirer 2 Place: Rajkot, Gujarat Date: August 14, 2026 Enclosed:Annexure A ****** A!!EXURE -A !ame of the Target Company: Parmax Pharma Limited 3741300 !ame(s) of the acquirer and Acquirer/ Pre Post Percentage of sr.no. Persons Acting in Concert Percentage PAC Shareholding Shareholding Shareholding (PAC) with the acquirer 1 DHIRE! CHA!DULAL SHAH Acquirer 1 0.00 0.00 467,238 12.49 2 SU!IL CHI!UBHAI SHAH Acquirer 2 0.00 0.00 71,077 1.90 3 DHAIRYA DHIRE! SHAH PAC 1 0.00 0.00 93,448 2.50 4 HIRE! PRAVI! DOSHI PAC 2 0.00 0.00 168,206 4.50 5 SHEETAL HIRE! DOSHI PAC 3 0.00 0.00 18,690 0.50 6 !IRMAL SU!ILBHAI SHAH PAC 4 32,500 0.87 124,597 3.33 7 RUPA SU!IL SHAH PAC 5 53,520 1.43 53,520 1.43 8 VIJAYKUMAR !ATVARLAL SHIYA!I PAC 6 0.00 0.00 124,597 3.33 9 KAMLESH !ATVARLAL SHIYA!I PAC 7 7,500 0.20 124,597 3.33 10 ABHAY CHI!UBHAI SHAH PAC 8 249394.00 6.67 249,394 6.67 11 UMA!G ALKESH GOSALIA PAC 9 200,000 5.35 200,000 5.35 12 MEE!A ALKESH GOSALIA PAC 10 474,800 12.69 474,800 12.69 TOTAL 1,017,714 27.20 2,170,164 58.01